Oncology

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors in dogs.

The funds will be used to support pet owners who cannot afford chemotherapy, surgery and other lifesaving treatment.

One of the biggest challenges is knowing when and where to refer a client.

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum.

Renowned American physician‑scientist Frederick R. Appelbaum, MD, discusses the development of bone marrow transplantation as a curative therapy at the 2025 ACVIM Forum.

Practical suggestions for veterinary professionals

Medicus Pharma submitted a product development plan to the FDA for an investigational new animal drug designation.

When patients come in the clinic, what red flags could general practitioners be on the look out for to indicate cancer?

Lola, a 9-year-old golden retriever, was referred to UC Davis William R. Pritchard Veterinary Medical Teaching Hospital after she was diagnosed with oral melanoma

Surgeons at Washington State University’s Veterinary Teaching Hospital removed a pheochromocytoma from a 12-year-old dog named Jessie

OST-HER2 could be a frontline treatment for dogs and humans

Petco Love’s donations to the UC Davis School of Veterinary Medicine are helping patients like Diamond, a 12-year-old Pitbull terrier with hemangiosarcoma

A 9-year-old Catahoula mix presented to the veterinary clinic with a limp on his left front leg

Benevet Oncology will adapt Privo Technologies’ platforms to advance cancer treatments for animals

The innovation also has the potential to detect other diseases in livestock, in addition to detecting up to 200 types of cancers

ELIAS Cancer Immunotherapy is an adoptive cell therapy treatment for canine osteosarcoma

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on key innovations in veterinary oncology

Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session

Lovey presented to the clinic lethargic, with inappetence but consuming plenty of water, and a bulge on her abdomen when lying down

The type of lesion will guide treatment and prognosis

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

AI Masses is an addition to Zoetis’ Vetscan Imagyst platform

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.

Over the next 3 years, IDEXX Cancer Dx will expand to include most canine cancer cases

Integrative therapies can enhance a patient’s survival and quality of life

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights.

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), discusses some of the latest advances in veterinary oncology

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), discusses his lecture “Mast Cell Tumors: The Latest and Greatest,” in an interview with dvm360

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), talks about his lecture “Lymphoma – What’s New?”, presented at the Fetch dvm360 conference in Atlantic City, New Jersey

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), talks about compounded CCNU, as well as the precision of 503B outsourcing facilities